LD |
Linear dichroism |
AASLD |
American Association for the Study of Liver Diseases |
ALT |
Alanine Aminotransferase |
AMPK |
AMP-activated Protein Kinase |
APOC3 |
Adipoprotein C3 |
AST |
Aspartate Aminotransferase |
BMI |
Body Mass Index |
CB2 |
Cannabinoid Receptor 2 |
CK-18 |
Cytokeratin 18 |
CT |
Computerized Tomography |
CYP2E1 |
Cytochrome P450 family 2 subfamily E member 1 |
DGAT2 |
Diacylglycerol O-Acyltransferase 2 |
DHA |
Docosahexaenoic Acid |
DPP-4 |
Incretin Mimetics and Dipeptidyl Peptidase-4 |
EASL |
European Association for the Study of the Liver |
ELF |
Enhanced Liver Fibrosis |
FTO |
Fat Mass and Obesity associated |
FXR |
Farnesoid X Receptor |
GCKR |
Glucokinase Regulatory Protein |
GGT |
γ-glutamyl Transferase |
GLP1 |
Glucagon-Like Peptide-1 |
GRP-120 |
G Protein-coupled Receptor 120 |
GWAS |
Genome-Wide Association Study |
HDL |
High-Density Lipoprotein |
HPC |
Hepatic Progenitor Cells |
HSC |
Hepatic Stellate Cells |
IL-6 |
Interleukin 6 |
IR |
Insulin Resistance |
IRS-1 |
Insulin Receptor Substrate-1 |
IUGR |
Intrauterine Growth Restriction |
KC |
Kupffer Cells |
KLF-6 |
Kruppel-Like Factor 6 |
LDL |
Low Density Lipoprotein |
LFTs |
Liver Function Tests |
LPIN1 |
Lipin 1 |
LYPLAL1 |
Lysophospholipase-Like 1 |
MC4R |
Melanocortin 4 Receptor |
NAFLD |
Non-Alcoholic Fatty Liver Disease |
NASH |
Non-Alcoholic Steatohepatitis |
NCAN |
Neurocan |
NKT |
Natural Killer T lymphocytes |
PNFI |
Pediatric NAFLD Fibrosis Index |
PNPLA3 |
Adiponutrin/Patatin-like Phospholipase Domain-containing 3 |
PPARg |
Peroxisome-Proliferator Activated Receptor-γ |
PPP1R3B |
Protein Phosphatase 1 Regulatory Subunit 3b |
PYY |
Peptide YY |
ROS |
Reactive Oxygen Species |
SLD |
Steatotic Liver Disease |
SOD2 |
Manganese-dependent Superoxide Dismutase |
SREBP1c |
Sterol Regulatory Binding Element |
TNF-α |
Tumor Necrosis Factor α |
TONIC |
Treatment of NAFLD in Children |